MONTREAL, QC – August 12, 2025 – MY01, an innovative medical technology company focused on transforming the diagnosis of limb perfusion injuries, announced the successful completion of an independent audit of its Continuous Perfusion Sensing Technology (CPST) Platform®. The comprehensive SOC2 Type II report issued by a leading third-party auditor provides an unqualified opinion, affirming that MY01’s system consistently meets stringent industry standards for design, implementation, and operational effectiveness.
The audit, covering the period from March 1, 2025, to June 1, 2025, confirmed that MY01’s CPST Platform® was designed and implemented in accordance with all relevant criteria. Furthermore, the report stated that the controls within the system were suitably designed and, critically, operated effectively throughout the audited period, providing reasonable assurance that MY01’s service commitments and system requirements were consistently achieved.
“This unqualified opinion is a testament to MY01’s unwavering commitment to security and reliability in our technology,” said Patrick Beaucaire, Director of New Product Introduction and Sustaining Engineering. “This independent opinion offers our users and partners enhanced confidence in the system’s integrity and performance. It reflects the dedication of our entire team to delivering robust and trustworthy solutions.”
The successful audit reinforces MY01’s position as a trusted provider in the medical technology space, demonstrating a strong adherence to best practices in system design and control effectiveness. This achievement is expected to further strengthen customer and partner relationships and support MY01’s continued growth in the market.
About MY01 Inc.
Founded in 2019 and based in Montreal, MY01 envisions a world where every disease is quantifiable, enabling precise, personalized care for all patients. At MY01, our Continuous Perfusion Sensing Technology (CPST) Platform has the ability to transform trauma programs by translating complex biological signs into dynamic, actionable, real-time data to inform better decision-making, thereby reducing variation in care and delivering better outcomes, allowing hospitals to allocate resources as efficiently as possible. MY01 is commercial in the USA, Europe, and Canada, setting new standards in healthcare.